|
View
Demonstration Now
Now
with a money back guarantee!
Testimonials
More
information
|
Interactive
Breathing Device Found Effective
in Lowering High Systolic Blood Pressure
San Francisco, CA. - March
16, 2005 - Frost & Sullivan will
present its 2005 Hypertension Treatment Technology Innovation of the
Year Award to InterCure, Inc. for its pioneering Interactive
Respiratory-Pacing technology, and in particular for its device RESPeRATE
To Lower Blood Pressure� - the only FDA-cleared non-drug
medical device clinically proven to lower high blood pressure. The
Award will be presented at tonight's 2nd annual Excellence in
Medical Devices Awards Banquet.
As over 60 million Americans
suffer from hypertension and only approximately 30 percent of them
successfully control their blood pressure, RESPeRATE�
is expected to influence the treatment of hypertension extensively.
With multiple published clinical
trials and thousands of advocates, both patients and physicians, RESPeRATE�
is rapidly becoming a part of the standard of care for the treatment
of hypertension. Besides being the only therapeutic self-care device
treating a major cardiovascular condition, RESPeRATE� has
become the first hypertension treatment available over-the-counter
(OTC).
"This device uses a
patented interactive respiratory-pacing technology to pace a
patient's breathing from the normal rate of 14 to 19 breaths/minute,
to the therapeutic zone of under 10 breaths/minute," explains
Frost & Sullivan research analyst Miriam Nagel. "Within
minutes, muscles surrounding the small blood vessels relax to allow
the blood to flow more freely, reducing high blood pressure. When
used 3 to 4 times a week for as little as 15 minutes at a time, RESPeRATE�
was shown to reduce high blood pressure on a sustained basis by an
average of 14/9 mmHg."
Nagel further explains that
"This battery operated device, about the size of a paperback
book, takes advantage of the body's natural tendency to follow
external rhythms. The RESPeRATE�
kit consists of a computerized control box, a respiration sensor,
and headphones. By monitoring the patient's breathing rate and
pattern, the device creates a personalized melody of two distinct
tones - one tone for inhalation and one for exhalation,"
observes Nagel. "As patients listen to the melody and
synchronize their breathing with these tones, the device gradually
prolongs the exhalation tone, thereby pacing users to the slower
therapeutic breathing zone."
In addition to RESPeRATE�
To Lower Blood Pressure, InterCure has incorporated the technology
platform in a second device, InTone�, a dyspnea-improving
device for patients prone to mild-to-moderate heart failure. InTone
has been tested successfully in Phase IIa clinical trials in which
it has met or exceeded primary endpoints including significant
improvements in QOL (quality of life), 6-minutes walk, ejection
fraction, and pulmonary artery pressure. .
Frost & Sullivan presents
its Technology Innovation of the Year Award to a company that has
carried out new research that has resulted in innovations that have
brought significant contributions to the industry in terms of
adoption, change, and competitive posture. It recognizes the quality
and depth of a company's research and development program, as well
as the vision and risk-taking that enabled it to undertake such an
endeavor in its industry.
Held in San Francisco, CA.,
Frost & Sullivan's 2005 Excellence in Medical Devices Awards
Banquet honors world-class companies for outstanding performance and
achievements in the medical devices industry.
About InterCure Inc.
InterCure (www.intercure.com)
is a medical device company that creates and sells products that
harness the therapeutic power of breathing for the treatment of
hypertension, heart failure, respiratory diseases and other
conditions. With 7 successful clinical trials, RESPeRATE�
(www.resperate.com),
InterCure's first product, became the only non-drug medical device
indicated by the FDA for the adjunctive treatment of hypertension.
Contact:
Tom Kirwan
201.720.7750 x 7136
tkirwan@intercure.com
About Frost & Sullivan
Frost & Sullivan, a global
growth consulting company founded in 1961, partners with clients to
create value through innovative growth strategies. The foundation of
this partnership approach is our Growth Partnership Services
platform, whereby we provide industry research, marketing
strategies, consulting and training to our clients to help grow
their business. A key benefit that Frost & Sullivan brings to
its clients is a global perspective on a broad range of industries,
markets, technologies, econometrics, and demographics. With a client
list that includes Global 1000 companies, emerging companies, as
well as the investment community, Frost & Sullivan has evolved
into one of the premier growth consulting companies in the world.
For more information, visit www.frost.com.
Contact:
Stacie Jones
210.247.2450
Stacie.jones@frost.com
|
